Search
for
Sort by
Research 31–60 of 328
- Ottawa, Ontario, Canada, February 13–16, 2013
- Contents
- Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus
- Cutaneous Lupus Erythematosus
- Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Antibody Drug Conjugates
- Persistent Panniculitis in Dermatomyositis
- LUPUS VASCULITIS
- Modern and Promising Strategies for Treatment of Alopecia in the United States: Clinical and Pharmacological, Marketing, Regulatory, SWOT Analysis
- Subject Index
- NUDT15 polymorphism explains serious toxicity to azathioprine in Indian patients with chronic immune thrombocytopenia and autoimmune hemolytic anemia: a case series
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- Primary cicatricial alopecia
- Skin grafting for the treatment of chronic leg ulcers – a systematic review in evidence‐based medicine
- Skin disease in pregnancy
- Treatment strategies for alopecia
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- New changes in pregnancy and lactation labelling: Review of dermatologic drugs
- The Significance of Scalp Involvement in Pemphigus: A Literature Review
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- The eye and the skin in endocrine metabolic diseases
- The spectrum of nephrocutaneous diseases and associations
- Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology
- Abstracts
- Cutaneous Reactions to Drugs
- Dermatologic Adverse Events from Cancer Treatments
- Skin
- Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
- Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities